171 related articles for article (PubMed ID: 33045947)
1. Modern View of Neutrophilic Asthma Molecular Mechanisms and Therapy.
Shilovskiy IP; Nikolskii AA; Kurbacheva OM; Khaitov MR
Biochemistry (Mosc); 2020 Aug; 85(8):854-868. PubMed ID: 33045947
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Bruton's tyrosine kinase and IL-2 inducible T-cell kinase suppresses both neutrophilic and eosinophilic airway inflammation in a cockroach allergen extract-induced mixed granulocytic mouse model of asthma using preventative and therapeutic strategy.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Siddiqui N; Al-Harbi MM; Attia SM; Bakheet SA
Pharmacol Res; 2019 Oct; 148():104441. PubMed ID: 31505252
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
Barnes PJ
J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
[TBL] [Abstract][Full Text] [Related]
4. Neutrophilic Asthma and Potentially Related Target Therapies.
Nair P; Prabhavalkar KS
Curr Drug Targets; 2020; 21(4):374-388. PubMed ID: 31660822
[TBL] [Abstract][Full Text] [Related]
5. Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma.
Morishima Y; Ano S; Ishii Y; Ohtsuka S; Matsuyama M; Kawaguchi M; Hizawa N
Clin Dev Immunol; 2013; 2013():609395. PubMed ID: 24454477
[TBL] [Abstract][Full Text] [Related]
6. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and therapeutic strategies for non-T2 asthma.
Sze E; Bhalla A; Nair P
Allergy; 2020 Feb; 75(2):311-325. PubMed ID: 31309578
[TBL] [Abstract][Full Text] [Related]
8. Advanced Molecular Knowledge of Therapeutic Drugs and Natural Products Focusing on Inflammatory Cytokines in Asthma.
Lin SC; Shi LS; Ye YL
Cells; 2019 Jul; 8(7):. PubMed ID: 31284537
[TBL] [Abstract][Full Text] [Related]
9. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
Fajt ML; Wenzel SE
J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharides promote a shift from Th2-derived airway eosinophilic inflammation to Th17-derived neutrophilic inflammation in an ovalbumin-sensitized murine asthma model.
Zhao S; Jiang Y; Yang X; Guo D; Wang Y; Wang J; Wang R; Wang C
J Asthma; 2017 Jun; 54(5):447-455. PubMed ID: 27589490
[TBL] [Abstract][Full Text] [Related]
11. T
Xie Y; Abel PW; Casale TB; Tu Y
J Allergy Clin Immunol; 2022 Feb; 149(2):467-479. PubMed ID: 34953791
[TBL] [Abstract][Full Text] [Related]
12. IL-17 in severe asthma. Where do we stand?
Chesné J; Braza F; Mahay G; Brouard S; Aronica M; Magnan A
Am J Respir Crit Care Med; 2014 Nov; 190(10):1094-101. PubMed ID: 25162311
[TBL] [Abstract][Full Text] [Related]
13. CCR5 attenuates neutrophilic airway inflammation exacerbated by infection with rhinovirus.
Hossain FMA; Park SO; Kim HJ; Eo JC; Choi JY; Uyangaa E; Kim B; Kim K; Eo SK
Cell Immunol; 2020 May; 351():104066. PubMed ID: 32089258
[TBL] [Abstract][Full Text] [Related]
14. Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease.
Horvat JC; Starkey MR; Kim RY; Beagley KW; Preston JA; Gibson PG; Foster PS; Hansbro PM
J Immunol; 2010 Apr; 184(8):4159-69. PubMed ID: 20228193
[TBL] [Abstract][Full Text] [Related]
15. Recombinant HMGB1 A box protein inhibits Th17 responses in mice with neutrophilic asthma by suppressing dendritic cell-mediated Th17 polarization.
Zhang F; Huang G; Hu B; Qian GS; Song Y
Int Immunopharmacol; 2015 Jan; 24(1):110-8. PubMed ID: 25479722
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma.
Pelaia G; Vatrella A; Busceti MT; Gallelli L; Calabrese C; Terracciano R; Maselli R
Mediators Inflamm; 2015; 2015():879783. PubMed ID: 25878402
[TBL] [Abstract][Full Text] [Related]
17. Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype?
Bruijnzeel PL; Uddin M; Koenderman L
J Leukoc Biol; 2015 Oct; 98(4):549-56. PubMed ID: 25977288
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1β.
Gao P; Gibson PG; Baines KJ; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Zhang J; Simpson JL
Respir Res; 2015 Jan; 16(1):5. PubMed ID: 25616863
[TBL] [Abstract][Full Text] [Related]
19. The treatment targets of asthma: from laboratory to clinic.
Fang C; Corrigan CJ; Ying S
Inflamm Allergy Drug Targets; 2008 Jun; 7(2):119-28. PubMed ID: 18691142
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of T
Liu W; Liu S; Verma M; Zafar I; Good JT; Rollins D; Groshong S; Gorska MM; Martin RJ; Alam R
J Allergy Clin Immunol; 2017 May; 139(5):1548-1558.e4. PubMed ID: 27702673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
